PetMed Express Reports Board and Executive Compensation Changes
Ticker: PETS · Form: 8-K · Filed: Sep 27, 2024 · CIK: 1040130
| Field | Detail |
|---|---|
| Company | Petmed Express Inc (PETS) |
| Form Type | 8-K |
| Filed Date | Sep 27, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-changes, executive-compensation, governance
Related Tickers: PETS
TL;DR
PETS board shake-up and exec pay changes filed today.
AI Summary
PetMed Express, Inc. filed an 8-K on September 27, 2024, reporting changes in its board of directors and executive compensation arrangements. The filing indicates a departure of directors and the election of new directors, alongside updates to the compensatory arrangements for certain officers. Specific details regarding the individuals involved and the exact nature of the compensation changes were not fully elaborated in the provided text but are central to this report.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy, governance, or financial outlook, impacting investor confidence and stock performance.
Risk Assessment
Risk Level: medium — Changes in board and executive compensation can indicate internal shifts that may affect future performance or strategy.
Key Players & Entities
- PetMed Express, Inc. (company) — Registrant
- September 27, 2024 (date) — Date of report
- Florida (location) — State of incorporation
- 420 South Congress Avenue, Delray Beach, Florida 33445 (address) — Principal executive offices
FAQ
What specific changes were made to the board of directors of PetMed Express, Inc.?
The filing indicates the departure of directors and the election of new directors, though specific names and dates of these changes are not detailed in the provided text.
What are the details of the compensatory arrangements for certain officers mentioned in the filing?
The filing states that there are updates to the compensatory arrangements of certain officers, but the specific details of these arrangements are not provided in the excerpt.
When was this Form 8-K filed with the SEC?
This Form 8-K was filed on September 27, 2024.
What is the principal executive office address for PetMed Express, Inc.?
The principal executive office is located at 420 South Congress Avenue, Delray Beach, Florida 33445.
What is the fiscal year end for PetMed Express, Inc.?
The fiscal year end for PetMed Express, Inc. is March 31.
Filing Stats: 713 words · 3 min read · ~2 pages · Grade level 10.2 · Accepted 2024-09-27 16:10:44
Key Financial Figures
- $0.0001 — 0,000 shares of common stock, par value $0.0001 per share, of the Company's common stoc
Filing Documents
- pets-20240927.htm (8-K) — 34KB
- exhibit1012024inducementin.htm (EX-10.1) — 126KB
- exhibit1011formrsuaward.htm (EX-10.1 1) — 30KB
- exhibit1012formpsuaward.htm (EX-10.1 2) — 33KB
- exhibit1013formrsa.htm (EX-10.1 3) — 33KB
- exhibit1014formofstockopti.htm (EX-10.1 4) — 44KB
- 0001040130-24-000110.txt ( ) — 476KB
- pets-20240927.xsd (EX-101.SCH) — 2KB
- pets-20240927_lab.xml (EX-101.LAB) — 21KB
- pets-20240927_pre.xml (EX-101.PRE) — 12KB
- pets-20240927_htm.xml (XML) — 3KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1 PetMed Express, Inc. 2024 Inducement Incentive Plan. 10.1.1 Form of Restricted Stock Unit Award under 2024 Inducement Incentive Plan. 10.1.2 Form of Performance Stock Unit Award under 2024 Inducement Incentive Plan. 10.1.3 Form of Restricted Stock Award under 2024 Induc e ment Incentive Plan. 10.1.4 Form of Stock Option Award under the 2024 Inducement Incentive Plan. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: September 27, 2024 PETMED EXPRESS, INC. By: /s/ Sandra Y. Campos Name: Sandra Y. Campos Title: Chief Executive Officer and President 3